THREAD Launches New Adaptive Trials Solution to Support the Most Complex Research Designs

Platform enhancement provides Sponsors/CROs a novel, configurable approach for complex cohorts in basket trials, umbrella trials, and multi-arm studies

CARY, N.C., 08 JUL 2026 – THREAD, a leading no-code technology platform for decentralized clinical trial (DCT) and eCOA solutions, today announced the release of its new platform enhancement that enables research teams to manage multiple participant pathways, indications, and workflows within a single study configuration. This platform enhancement was launched working directly with biopharma and CRO clients to support increasingly complex trial designs including basket trials (one therapy across multiple diseases), umbrella trials (multiple therapies within a single disease), and multi-arm studies (multiple treatment groups under one protocol). 

This new configurable technology feature helps sponsors reduce setup timelines, simplify protocol amendments, and lower operational costs with greater flexibility for adaptive clinical trial designs. Sponsors and CROs can utilize this feature seamlessly within THREAD's participant app, version management capabilities, and role-based access controls, creating an instantly configurable solution for complex study designs. Key benefits include:

• Faster study setup and rapid protocol amendment adjustments
• Dynamic participant pathways that adapt to individual study requirements
• Greater governance with role-based controls for participant transitions between cohorts
• Seamless participant experiences through automated task and visit management

"Clinical trial complexity continues to increase, requiring our technology platform to offer more options via instant configurability,” said John Reites, Co-founder, CEO of THREAD. "This enhancement gives sponsors and CROs the flexibility to adapt studies as they evolve while reducing operational burden, accelerating timelines, and delivering a better experience for both research sites and patients."

THREAD continues to help sponsors execute complex clinical trials, including adaptive trials, with greater speed, efficiency, and lower costs. To learn more about THREAD’s clinical research technology and to see a quick demonstration visit, https://discover.threadresearch.com/schedule-demo.

##

About THREAD

THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. Through its uniquely combined research technology and scientific consulting services, THREAD helps life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and human-centered.

THREAD has been recognized as a leader by Everest Group in its Decentralized Clinical Trial Product PEAK Matrix® Assessments from 2021 through 2023, is positioned in the Leaders Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment, and is named a Major Contender in Everest Group’s Life Sciences eCOA Products PEAK Matrix® Assessment 2025.

Media Contact
Les Yates
THREAD
media@THREADresearch.com